TP53 and central nervous system cancer: Mechanistically, we observed distinct ATRi-induced molecular alterations in glioma cells and cell cycle alterations connected to p53 signaling and depending on cellular p53 status (Figs. 1 and 3, Supplementary Figure S 9, S10).